The Pharmacy Is Out of Your ADHD Meds Again. The Survival Guide for Schedule II Shortages

One of the harder posts in the parenting threads we studied: a six-year-old whose pharmacy ran out mid-week, two missed days, and behavior that scared her family. The stimulant shortages that started in 2022 have rolled on in waves since, and they collide with the strictest prescription rules in medicine: Schedule II drugs allow no refills, standard 30-day fills, and until recently no transfers between pharmacies. The tactics below are the difference between an annoying week and a zero-pill one.

Why this drug class is uniquely miserable in a shortage

• No refills exist: every month's supply is a brand-new prescription, sent to one specific pharmacy. If that pharmacy is out, the prescription historically sat there uselessly.
• 30-day fills: federal law permits prescribers to issue up to a 90-day supply as multiple sequential prescriptions, but many states, insurers, and prescribers hold stimulants to 30 days, so most people shop monthly.
• Early-fill windows are tight: insurers typically allow refills only within a couple of days of exhaustion for controlled substances, so there's little slack to build a buffer legally.
• Manufacturing quotas: the DEA sets annual production caps for stimulants, which is part of why shortages persist; the FDA's shortage database shows which products and strengths are actually affected at any moment.

The week-of playbook, in order

1. Ask your own pharmacy two exact questions: "When is your next delivery, and can you do a partial fill today with the balance owed?" Partial fills of Schedule II prescriptions are permitted (the remainder must generally be dispensed within 30 days), and a 10-day partial beats a zero-pill week.
2. Call around before involving the prescriber: independents and grocery-store pharmacies often have stock when big chains are dry, and some chains will check nearby stores' inventory for you. Ask: "Do you have [drug, strength, generic or brand] in stock, or when do you expect it?"
3. Use the transfer rule almost nobody knows: since August 28, 2023, DEA regulations allow a one-time transfer of an unfilled electronic Schedule II-V prescription between pharmacies at the patient's request, pharmacist to pharmacist. When you find stock at pharmacy B, ask B's pharmacist to request the transfer from A. If either pharmacy can't or won't (systems vary), the fallback is asking the prescriber to cancel and re-send to B.
4. Then ask the prescriber about equivalents: two 10mg tablets when 20mg is short, a different extended-release brand or generic of the same molecule, an immediate-release bridge for an extended-release gap, or a different-but-similar stimulant when your molecule is regionally dry. Prescribers did this constantly through the shortage years (CHADD keeps practical guidance); the request that helps them help you is naming which strengths the pharmacy said it HAS.
5. Insurance hiccup on the substitute? A formulary exception or prior auth for the in-stock version usually clears with a shortage note from the prescriber, and cash prices on generic stimulants are often modest enough to bridge a week while it processes.

The prevention habits that end the monthly panic

• Fill on the first legal day, every month: ask the pharmacy what your earliest fill date is and calendar it. Consistently early filling builds the only buffer the rules allow.
• Keep the dose inventory honest: know exactly how many days remain before you call anyone; every conversation goes better with "we have 4 days left" than "we're almost out."
• Ask about 90-day prescribing where your state and insurer allow it (written as sequential prescriptions): one pharmacy trip a quarter also means one shortage exposure a quarter.
• Log every stockout: which pharmacy, which strength, what they suggested. Patterns emerge (one chain's supplier is chronically short; the independent two towns over never is), and the log powers the next month's first call.